Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 3/20 | 0.46 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA5A | P35218 | 3/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 2/20 | 0.46 |
| ▸ | CA6 | P23280 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | NT5E | P21589 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10473101 | 0.96 | CA1 (0.43) | CA1CA2CA9CA5ACA5B | |
| SCHEMBL5315226 | 0.73 | — | — | |
| SCHEMBL2772640 | 0.73 | — | — | |
| SCHEMBL5155872 | 0.70 | — | — | |
| SCHEMBL28178943 | 0.70 | — | — | |
| SCHEMBL467288 | 0.70 | — | — | |
| Hydrochloric Acid SCHEMBL5155881 | 0.70 | — | — | |
| SCHEMBL31508509 | 0.67 | — | — | |
| SCHEMBL27673478 | 0.67 | — | — | |
| SCHEMBL29088734 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1111453-A | Aryl sulfonamide derivatives and pharmaceutical compositions containing the same | NIPPON KOKAN KK (JP) | 1995-11-08 | — | — | CN | claimed |
| JP-9327972-A | — | — | None | — | — | JP | disclosed |
| US-12571023-B2 | Composition and methods for affinity directed enrichment of rare species | SPARK MOLECULAR DIAGNOSTICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| CN-115417852-B | 5-trifluoromethyl-4H-thiopyran derivatives and process for preparing same | 华东师范大学 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023119910-A1 | RADIATION-SENSITIVE COMPOSITION, RESIST PATTERN FORMATION METHOD, ACID GENERATOR, AND COMPOUND | JSR株式会社 | 2023-06-29 | — | — | WO | disclosed |
| CN-114181530-A | Bioelectrode composition, bioelectrode, method for producing bioelectrode, and silicon material particle | 信越化学工业株式会社 | 2022-03-15 | — | — | CN | disclosed |
| CN-112400026-A | Compositions and methods for affinity directed enrichment of rare species | CY分子诊断公司 | 2021-02-23 | — | — | CN | disclosed |
| US-20150259295-A1 | SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS | HOFFMANN-LA ROCHE INC. | 2015-09-17 | — | — | US | disclosed |
| EP-2864294-A1 | SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS | F. Hoffmann-La Roche AG (CH) | 2015-04-29 | — | — | EP | disclosed |
| WO-2013189862-A1 | SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS | F. HOFFMANN-LA ROCHE AG (CH) | 2013-12-27 | — | — | WO | disclosed |
| US-5877199-A | ALZHEIMER'S DISEASE; SEDATIVE | SANKYO COMPANY, LIMITED (JP) | 1999-03-02 | — | — | US | disclosed |
| WO-1999005125-A1 | SUBSTITUTED N-ARYL-N-THIOXOCARBONYL SULFONAMIDES AS HERBICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1999-02-04 | — | — | WO | disclosed |
| JP-H09327972-A | THERMAL RECORDING MATERIAL | NIPPON PAPER IND CO LTD | 1997-12-22 | — | — | JP | disclosed |
| US-5607954-A | Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals | HOECHST AKTIENGESELLSCHAFT (DE) | 1997-03-04 | — | — | US | disclosed |
| CN-1111453-A | Aryl sulfonamide derivatives and pharmaceutical compositions containing the same | NIPPON KOKAN KK (JP) | 1995-11-08 | — | — | CN | disclosed |
| US-4908056-A | Herbicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-13 | — | — | US | disclosed |
| US-4908056-A | Herbicides | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-03-13 | — | — | US | disclosed |
| US-4838925-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-13 | — | — | US | disclosed |
| US-4838925-A | HERBICIDES | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0244166-A2 | Heterocyclic acetyl sulfonamides | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1987-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12571023-B2 | Composition and methods for affinity directed enrichment of rare species | CPSF6, CPSF1, NUDT21 | CA1 955/4885CA2 1956/4885CA9 1462/4885 |
| US-20150259295-A1 | SUBSTITUTED PYRAZOLE COMPOUNDS AS LPAR ANTAGONISTS | LPAR3, LPAR1, LPAR2 | CA1 4864/4885CA2 4168/4885CA9 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.